Olanzapine use in a patient with schizophrenia and the risk of diabetes.
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D005260:Female; D006801:Humans; D000077152:Olanzapine; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine